Abraxane drug gets FDA approval for patients with advanced pancreatic cancer

[News]

The U.S. Food and Drug Administration today approved Abraxane for patients with advanced pancreatic cancer, following 7 years of rigorous clinical trials overseen by Scottsdale Healthcare and the Translational Genomics Research Institute.

More... (http://www.news-medical.net/news/20130907/Abraxane-drug-gets-FDA-approval-for-patients-with-advanced-pancreatic-cancer.aspx)